1. Bariatric surgery is associated with lower risk of acute cardiovascular events in patients with obesity and hypertrophic cardiomyopathy. (14th October 2021) Authors: Miyashita, S; Zhao, Y; Hasegawa, K; Maurer, M; Fifer, M; Reilly, M; Takayama, H; Shimada, Y J Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comprehensive proteomics profiling identifies patients with late gadolinium enhancement on cardiac magnetic resonance imaging in the hypertrophic cardiomyopathy population. (14th October 2021) Authors: Lander, B S; Zhao, Y; Hasegawa, K; Maurer, M S; Fifer, M A; Reilly, M P; Shimada, Y J Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comprehensive proteomics profiling reveals molecular pathways that are differentially regulated in hypertrophic cardiomyopathy and correlate with clinical markers of disease severity. (14th October 2021) Authors: Shimada, Y J; Raita, Y; Liang, L W; Maurer, M S; Hasegawa, K; Fifer, M A; Reilly, M P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P3547Comparative effectiveness of alcohol septal ablation versus septal myectomy on acute cardiovascular events in patients with hypertrophic cardiomyopathy. (28th August 2018) Authors: Shimada, Y J; Goto, T; Takayama, H; Homma, S; Maurer, M S; Hasegawa, K Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy using proteomics profiling. (14th October 2021) Authors: Shimada, Y J; Raita, Y; Maurer, M S; Hasegawa, K; Fifer, M A; Reilly, M P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy using proteomics profiling. (3rd October 2022) Authors: Harano, N; Liang, L W; Hasegawa, K; Maurer, M S; Tower-Rader, A; Fifer, M A; Reilly, M P; Shimada, Y J Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prediction of worsening heart failure in patients with hypertrophic cardiomyopathy using plasma proteomics profiling. (3rd October 2022) Authors: Lumish, H; Liang, L W; Hasegawa, K; Maurer, M; Tower-Rader, A; Fifer, M A; Reilly, M P; Shimada, Y J Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Proteomics profiling reveals distinct molecular subtypes of hypertrophic cardiomyopathy with differential risks of major adverse cardiovascular events. (14th October 2021) Authors: Liang, L W; Raita, Y; Hasegawa, K; Fifer, M A; Maurer, M S; Reilly, M P; Shimada, Y J Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Proteomics profiling reveals signaling pathways associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy. (3rd October 2022) Authors: Lee, C; Liang, L W; Hasegawa, K; Maurer, M S; Tower-Rader, A; Fifer, M A; Reilly, M P; Shimada, Y J Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗